- Home
- MASS vs NVCT Comparison
MASS vs NVCT Comparison
Compare MASS & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MASS | NVCT |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.0M | 193.4M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MASS | NVCT |
|---|---|---|
| Price | $5.46 | $8.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $9.00 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 550.7K | 91.8K |
| Earning Date | 11-10-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $65,045,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 36.21 | N/A |
| 52 Week Low | $1.92 | $5.34 |
| 52 Week High | $9.34 | $11.52 |
Technical Indicators
Market Signals| Indicator | MASS | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 68.59 |
| Support Level | $5.03 | $8.00 |
| Resistance Level | $5.49 | $7.91 |
| Average True Range (ATR) | 0.30 | 0.51 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 40.85 | 72.07 |
Price Performance
Historical ComparisonAbout MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.